Related Experiment Video
Updated: May 11, 2026

Forward Genetics Screens Using Macrophages to Identify Toxoplasma gondii Genes Important for Resistance to IFN-γ-Dependent Cell Autonomous Immunity
Published on: March 12, 2015
Crystal structure of a macrophage migration inhibitory factor from Giardia lamblia
Garry W Buchko1, Jan Abendroth, Howard Robinson
1Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA. garry.buchko@pnnl.gov
Abstract:
Macrophage migration inhibitory factor (MIF) is a eukaryotic cytokine that affects a broad spectrum of immune responses and its activation/inactivation is associated with numerous diseases. During protozoan infections MIF is not only expressed by the host, but, has also been observed to be expressed by some parasites and released into the host. To better understand the biological role of parasitic MIF proteins, the crystal structure of the MIF protein from Giardia lamblia (Gl-MIF), the etiological agent responsible for giardiasis, has been determined at 2.30 Å resolution. The 114-residue protein adopts an α/β fold consisting of a four-stranded β-sheet with two anti-parallel α-helices packed against a face of the β-sheet. An additional short β-strand aligns anti-parallel to β4 of the β-sheet in the adjacent protein unit to help stabilize a trimer, the biologically relevant unit observed in all solved MIF crystal structures to date, and form a discontinuous β-barrel. The structure of Gl-MIF is compared to the MIF structures from humans (Hs-MIF) and three Plasmodium species (falciparum, berghei, and yoelii). The structure of all five MIF proteins are generally similar with the exception of a channel that runs through the center of each trimer complex. Relative to Hs-MIF, there are differences in solvent accessibility and electrostatic potential distribution in the channel of Gl-MIF and the Plasmodium-MIFs due primarily to two "gate-keeper" residues in the parasitic MIFs. For the Plasmodium MIFs the gate-keeper residues are at positions 44 (Y --> R) and 100 (V --> D) and for Gl-MIF it is at position 100 (V --> R). If these gate-keeper residues have a biological function and contribute to the progression of parasitemia they may also form the basis for structure-based drug design targeting parasitic MIF proteins.
Insights
The crystal structure of Macrophage Migration Inhibitory Factor (MIF) from Giardia lamblia reveals unique structural features compared to human MIF. These differences, particularly in the trimer channel, offer potential targets for new anti-parasitic drugs.
Area of Science:
- Structural Biology
- Immunology
- Parasitology
Background:
- Macrophage Migration Inhibitory Factor (MIF) is a crucial cytokine in immune responses, implicated in various diseases.
- Parasitic protozoa, including Giardia lamblia, can express and release their own MIF proteins into the host.
- Understanding parasitic MIF is vital for developing targeted therapies against protozoan infections.
Purpose of the Study:
- To determine the crystal structure of Macrophage Migration Inhibitory Factor (MIF) from Giardia lamblia (Gl-MIF).
- To compare the structural characteristics of Gl-MIF with human MIF (Hs-MIF) and MIF from Plasmodium species.
- To identify potential structural differences that could be exploited for drug design.
Main Methods:
- X-ray crystallography was used to determine the 3D structure of Gl-MIF at 2.30 Å resolution.
- Comparative structural analysis was performed between Gl-MIF, Hs-MIF, and Plasmodium MIF structures.
- Analysis focused on the trimeric structure and the central channel, including solvent accessibility and electrostatic potential.
Main Results:
- The Gl-MIF protein adopts a conserved α/β fold, forming a trimer as the biologically relevant unit.
- A central channel exists within the Gl-MIF trimer, differing in solvent accessibility and electrostatic properties compared to Hs-MIF.
- Key differences are attributed to specific 'gate-keeper' residues within the parasitic MIF structures, notably at position 100 (V to R) in Gl-MIF.
Conclusions:
- The determined Gl-MIF structure provides insights into parasitic MIF function.
- Structural variations in the trimer channel, influenced by gate-keeper residues, distinguish parasitic MIFs from human MIF.
- These unique structural features represent promising targets for the development of novel, structure-based anti-parasitic drugs.

